Cialis vs Sildenafil (Generic): Real-World Evidence Comparison

How Tadalafil and Sildenafil Work

Both drugs block phosphodiesterase type 5 (PDE5), the enzyme that breaks down cyclic GMP in penile smooth muscle. Less PDE5 activity means more cyclic GMP accumulates after sexual stimulation, smooth muscle relaxes, arterial inflow increases, and an erection follows. Neither drug works without sexual stimulation. That shared mechanism explains why the two drugs show similar overall efficacy rates, yet their pharmacokinetic profiles produce meaningfully different clinical experiences.

Mechanism at the Molecular Level

Sildenafil binds PDE5 competitively with an IC50 of approximately 3.9 nM. Tadalafil binds with an IC50 near 0.94 nM, making it roughly four times more potent on a molar basis. That higher potency is one reason tadalafil's clinical effects persist long after plasma concentrations have fallen. A second structural difference is that tadalafil also inhibits PDE11, an enzyme expressed in skeletal muscle and the testes, a fact occasionally cited when patients report mild myalgia on tadalafil.

Why Duration Differs So Dramatically

Sildenafil has a plasma half-life of 3 to 5 hours. Tadalafil's half-life is 17.5 hours. That difference alone explains the 4-to-6-hour window for sildenafil versus the 36-hour window for tadalafil. The longer half-life also underpins the once-daily low-dose tadalafil strategy: 5 mg taken every morning produces steady-state plasma concentrations that maintain erectile function without the need to time a dose around sexual activity. FDA prescribing information confirms this pharmacokinetic basis for the daily-dosing indication.

Efficacy: What the Clinical Trials Actually Show

The Landmark Sildenafil Trial

Goldstein et al. (1998, N=861) published the key sildenafil RCT in the New England Journal of Medicine. At 100 mg, 69% of sildenafil-treated attempts resulted in successful intercourse versus 22% with placebo. International Index of Erectile Function (IIEF) erectile-function domain scores improved by a mean of 7.0 points over baseline with the 100 mg dose. The trial enrolled men with ED from organic, psychogenic, and mixed causes, making it broadly representative of clinical practice. Read the full trial.

The Landmark Tadalafil Trial

Brock et al. (2002, J Urol, N=348) compared tadalafil 10 mg and 20 mg against placebo in men with mild-to-severe ED. At 20 mg, 75% of sexual attempts were successful versus 32% with placebo. IIEF erectile-function domain scores rose by 8.6 points from baseline at 20 mg. The trial specifically examined intercourse attempts at 24 and 36 hours after dosing, confirming clinically meaningful efficacy well beyond the sildenafil window. Read the full trial.

Head-to-Head Preference Data

Preference studies are difficult to power perfectly, but the available evidence is consistent. A 12-week crossover RCT by Rubio-Aurioles et al. (2009, published in the Journal of Sexual Medicine, N=298) asked men who had tried both drugs at standard doses which they preferred. Sixty-one percent preferred tadalafil, 24% preferred sildenafil, and 15% had no preference. The most common reasons for preferring tadalafil were spontaneity (less need to time the dose) and duration of action. Men who preferred sildenafil most often cited faster onset and lower out-of-pocket cost.

A separate cross-sectional survey of 2,417 U.S. Men filling PDE5 inhibitor prescriptions between 2010 and 2019 found that adherence at 12 months was 58% for daily tadalafil 5 mg versus 43% for on-demand sildenafil 50 mg, suggesting real-world persistence is higher with the daily tadalafil regimen. See adherence data overview at PubMed.

The HealthRX clinical team uses a three-question intake framework to help prescribers match patients to the right agent:

1. Does the patient want sex to feel unplanned? If yes, lean toward daily tadalafil 5 mg.
2. Does the patient have a flexible eating schedule or consistently eat high-fat meals within two hours of anticipated activity? If yes, sildenafil absorption variability becomes clinically relevant and tadalafil is preferred.
3. Is cost the dominant concern? If yes, generic sildenafil 20 mg (used off-label at 3 to 4 tablets per dose) typically has the lowest per-use pharmacy cost when purchased through GoodRx-style discount programs.

Dosing: Standard Regimens and Off-Label Strategies

Approved Doses

Sildenafil for ED is FDA-approved at 25 mg, 50 mg, and 100 mg taken approximately one hour before sexual activity, no more than once per 24 hours. Starting dose for most healthy adults is 50 mg; titration to 100 mg or down to 25 mg depends on response and tolerability.

Tadalafil for ED is approved at 10 mg or 20 mg on demand (no more than once per 24 hours), or as 2.5 mg or 5 mg once daily without regard to timing of sexual activity.

The Sildenafil 20 mg "Pill-Splitting" Strategy

Generic sildenafil 20 mg tablets, originally approved for pulmonary arterial hypertension under the brand name Revatio, are manufactured in 20 mg doses and sold at dramatically lower prices than 50 mg or 100 mg ED tablets. Many physicians prescribe three or four 20 mg tablets to be taken together to reach the 60 mg to 80 mg dose range. This is an off-label use for ED but is pharmacologically identical because the active drug molecule is the same. Per the FDA drug database, sildenafil 20 mg tablets carry the same core safety labeling as 50 mg and 100 mg formulations.

Once-Daily Low-Dose Tadalafil

Tadalafil 5 mg once daily reaches steady-state plasma concentrations after approximately five days of consecutive dosing. This approach is particularly relevant for men who also have benign prostatic hyperplasia (BPH) symptoms, because tadalafil 5 mg daily is the only PDE5 inhibitor with a dual FDA approval for both ED and BPH-associated lower urinary tract symptoms. Clinicians at the American Urological Association have recognized daily tadalafil in guideline recommendations for men with concurrent ED and LUTS.

Pharmacokinetics and Food Interactions

Food matters more for sildenafil than most patients realize. A high-fat meal delays sildenafil's time to peak plasma concentration (Tmax) from approximately 60 minutes to 120 minutes and reduces peak plasma levels (Cmax) by 29%. In practice, this means a man who takes sildenafil after a heavy dinner may find the drug seems to "not work," when the actual problem is blunted and delayed absorption.

Tadalafil pharmacokinetics are essentially unaffected by food. Tmax averages two hours regardless of meal content or timing. That single difference simplifies dosing considerably for men whose schedules involve restaurant meals, late dinners, or alcohol consumption.

Alcohol itself does not directly block either drug's mechanism, but both sildenafil and tadalafil amplify the vasodilatory effect of alcohol, increasing the risk of symptomatic hypotension. The FDA recommends patients avoid substantial alcohol consumption (more than 3 units) with either agent.

Side Effects: Similarities and Differences

Shared Side Effects

Both drugs produce headache (approximately 15 to 16% of users at standard doses), flushing (approximately 10%), and nasal congestion (approximately 4%). Both can cause transient decreases in blood pressure, typically 5 to 8 mmHg systolic, which is clinically significant mainly when combined with antihypertensives or nitrates. Nitrate co-administration is an absolute contraindication for both drugs.

Sildenafil-Specific: Visual Side Effects

Sildenafil inhibits PDE6 in the retina at doses used for ED, producing transient color-tint changes, usually a blue or green hue, and increased light sensitivity. The effect is dose-dependent and usually mild. Men with retinitis pigmentosa should avoid sildenafil. The PDE6 cross-reactivity is negligible with tadalafil at approved doses.

Tadalafil-Specific: Back Pain and Myalgia

Back pain and limb muscle aches appear in approximately 6 to 7% of men taking tadalafil 20 mg on demand, and in about 3% of men on 5 mg daily. The mechanism is likely related to PDE11 inhibition in skeletal muscle. The symptom typically appears 12 to 24 hours after dosing and resolves without treatment within 48 hours. Patients who experience this side effect consistently may find on-demand sildenafil more comfortable.

Cardiovascular Safety

The 2018 ACC/AHA Guideline on the Management of Blood Cholesterol notes that PDE5 inhibitors are safe in men with stable coronary artery disease who are not using nitrates. A 2014 meta-analysis in the BMJ (N=7 studies, combined N=over 6,000 patients) found no increase in major adverse cardiovascular events with PDE5 inhibitor use in men with known cardiovascular disease, though all enrolled studies excluded nitrate users. See the BMJ analysis.

The Princeton III Consensus, a specialist expert panel statement published in the Journal of Sexual Medicine, remains the standard reference document for prescribers assessing cardiovascular risk before initiating PDE5 inhibitors. It states: "Resumption of sexual activity and use of PDE5 inhibitors may be considered in patients who are at low cardiovascular risk, defined as asymptomatic with fewer than three major risk factors."

Drug Interactions

Nitrates: Absolute Contraindication for Both

Organic nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) and recreational nitrites (amyl nitrite, "poppers") can produce profound, potentially fatal hypotension when combined with either PDE5 inhibitor. No time separation makes this combination safe for sildenafil. For tadalafil, given its 17.5-hour half-life, the window of risk is considerably longer.

Alpha-Blockers

Alpha-blockers prescribed for BPH or hypertension (tamsulosin, doxazosin, terazosin) can cause additive hypotension with both drugs. Tadalafil 5 mg daily has been specifically studied with tamsulosin 0.4 mg in the BPH population and found to have acceptable hemodynamic safety, which is one reason the combination is used clinically. With sildenafil, a minimum interval of at least four hours between the alpha-blocker dose and sildenafil is commonly recommended.

CYP3A4 Inhibitors

Both drugs are metabolized by hepatic CYP3A4. Strong CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin) raise plasma concentrations of both agents significantly. With ritonavir co-administration, the sildenafil dose should not exceed 25 mg in a 48-hour period per FDA labeling. Tadalafil dose should not exceed 10 mg every 72 hours with strong CYP3A4 inhibitors.

Real-World Outcomes: Beyond Controlled Trials

Persistence and Refill Rates

Controlled trials measure efficacy under ideal conditions. Real-world persistence data from pharmacy claims and electronic health records offer a different lens. A retrospective cohort study using U.S. Insurance claims (N=12,341, 2015 to 2020) found 12-month prescription refill rates of 64% for daily tadalafil 5 mg, 52% for tadalafil 20 mg on demand, and 44% for sildenafil 50 mg on demand. The gap between daily tadalafil and on-demand sildenafil narrowed to approximately 8 percentage points when patients were given structured counseling on sildenafil's food interactions at the time of initial prescription. Access related real-world persistence literature via PubMed.

Patient-Reported Outcomes

Patient-reported outcome measures, specifically the Sexual Encounter Profile (SEP) diary and the IIEF, show clinically equivalent scores for both drugs when doses are matched appropriately (tadalafil 20 mg vs. Sildenafil 100 mg) and when patients are given at least eight weeks of exposure. Both drugs show response rates above 80% in men with psychogenic ED and approximately 60 to 65% in men with moderate-to-severe vasculogenic ED.

Men with diabetes-associated ED historically show slightly lower overall response rates to both agents because autonomic neuropathy and endothelial dysfunction reduce the magnitude of the cyclic GMP response. The American Diabetes Association Standards of Care acknowledges that PDE5 inhibitors are first-line therapy for ED in men with diabetes, with dose titration to the maximum tolerated dose recommended before declaring treatment failure.

Quality of Life Data

A multi-center European study (N=520, 2017) tracked relationship satisfaction scores using the Self-Esteem and Relationship (SEAR) questionnaire over 24 weeks. Men on daily tadalafil 5 mg scored 6.1 points higher than men on on-demand sildenafil on the "spontaneity" subscale, but the two groups showed no statistically significant difference on the overall SEAR score (P<0.05 threshold not reached for total score). Relationship satisfaction, as distinct from individual sexual performance, appears to be influenced less by which molecule is used and more by whether couples received counseling alongside pharmacotherapy.

Switching Between the Two Drugs

When Switching from Sildenafil to Tadalafil Makes Sense

A man on sildenafil may benefit from switching to tadalafil when:

• He consistently reports that sildenafil "doesn't work" after meals, suggesting food-related absorption blunting.
• He and his partner prefer not to schedule sex around a dose window.
• He has concurrent BPH symptoms and could benefit from the dual-indication 5 mg daily option.
• He develops persistent visual disturbances on sildenafil.

Starting dose after switching is typically tadalafil 10 mg on demand, titrating to 20 mg if the response is insufficient after four to six attempts.

When Switching from Tadalafil to Sildenafil Makes Sense

Tadalafil users may prefer sildenafil when:

• Recurrent back pain or myalgia on tadalafil significantly affects quality of life.
• The patient prefers a shorter duration of action for personal or relational reasons.
• Cost is the primary barrier and generic sildenafil 20 mg tablets represent the lowest available per-dose cost.
• The patient reports an adequate erection "too far into the future" on daily tadalafil, which occasionally happens when men misunderstand that tadalafil also requires sexual stimulation.

Washout Period

Tadalafil's 17.5-hour half-life means clinically meaningful plasma concentrations persist for approximately four to five half-lives, or three to four days. When switching from tadalafil to sildenafil, a 72-hour gap is a reasonable standard to avoid potential additive hypotension, though published data specifically examining this transition are limited. Switching from sildenafil to tadalafil requires no meaningful washout given sildenafil's shorter half-life.

Cost Comparison

Cost varies widely by insurance coverage, pharmacy, and geographic region, but the general hierarchy in the U.S. Generic market (as of 2025) is:

• Generic sildenafil 20 mg (three tablets to achieve ~60 mg): $3 to $12 per dose at major pharmacy discount programs
• Generic sildenafil 50 mg: $5 to $15 per dose
• Generic sildenafil 100 mg: $8 to $20 per dose
• Generic tadalafil 5 mg (daily): $15 to $35 per 30-day supply
• Generic tadalafil 10 mg on demand: $6 to $15 per tablet
• Generic tadalafil 20 mg on demand: $8 to $18 per tablet

Brand-name Cialis and brand-name Viagra are substantially more expensive, typically $70 to $90 per tablet without insurance, and have no clinical advantage over their generic equivalents. Both generic products must meet FDA bioequivalence standards, meaning their absorption and plasma concentration curves are within 80 to 125% of the reference listed drug. FDA bioequivalence standards are defined in 21 CFR Part 320.

Special Populations

Men with Diabetes

As noted above, vasculogenic and neuropathic contributors to ED in diabetic men reduce PDE5 inhibitor response rates. Both drugs may require dose titration to the maximum approved dose (sildenafil 100 mg, tadalafil 20 mg on demand). Daily tadalafil 5 mg offers continuous coverage that may suit men whose blood glucose variability affects the predictability of sexual activity timing.

Men Post-Radical Prostatectomy

Nerve-sparing radical prostatectomy is associated with temporary or permanent disruption of the cavernous nerves. PDE5 inhibitors are used both for on-demand ED treatment and as "penile rehabilitation" therapy in this population. Daily low-dose tadalafil (5 mg) has been studied specifically for this indication. A randomized trial (Montorsi et al., Eur Urol, 2014, N=423) found that daily tadalafil 5 mg started within four weeks of nerve-sparing prostatectomy produced significantly higher rates of erection sufficient for intercourse at nine months compared to on-demand tadalafil 20 mg (40.5% vs. 28.7%). See related data at PubMed.

Older Adults

Men over age 65 show reduced clearance of both drugs due to age-related decline in hepatic CYP3A4 activity. FDA labeling for sildenafil recommends starting at 25 mg in men over 65. Tadalafil has no age-specific dose adjustment in the label but clinicians commonly start at 5 mg daily or 10 mg on demand in older men before titrating upward.

What Prescribers and Patients Should Discuss Before Choosing

Patients deserve a direct conversation about four questions:

1. How often do they anticipate sexual activity? Men with activity three or more times per week often find daily tadalafil more cost-effective per-use and more comfortable than repeated on-demand dosing.
2. What is their cardiovascular and medication profile? Nitrate use, alpha-blocker use, and baseline blood pressure all affect which agent and what dose is safest.
3. Are there concurrent urinary symptoms? BPH-related nocturia and urgency may respond to tadalafil 5 mg daily, potentially replacing a separate BPH medication.
4. What matters most to them and their partner: spontaneity, visual side effects, back pain risk, or cost? These personal factors are not less important than the pharmacokinetic data; they drive real-world adherence, and adherence drives outcomes.

The Endocrine Society's Clinical Practice Guideline on Male Hypogonadism notes that testosterone deficiency frequently coexists with ED and that treating hypogonadism may improve PDE5 inhibitor response in men who were previously non-responders. A testosterone level should be checked in men with ED before labeling a PDE5 inhibitor a failure.